Prior antiarrhythmic drug use and the outcome of atrial fibrillation ablation

Europace

Volumn 14, Issue 5, 2012, Pages 646-652

  Winkle, Roger A ^a,b   Mead, R Hardwin ^a,b   Engel, Gregory ^a,b   Kong, Melissa H ^a,b   Patrawala, Rob A ^a,b  

^a Silicon Valley Cardiology   (United States)

^b SEQUOIA HOSPITAL   (United States)

Author keywords

Ablation; AF ablation outcomes; Antiarrhythmic drugs; Atrial fibrillation

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; DISOPYRAMIDE; DOFETILIDE; DRONEDARONE; FLECAINIDE; PROCAINAMIDE; PROPAFENONE; QUINIDINE; SOTALOL;

ADULT; AGED; ARTICLE; CATHETER ABLATION; DISEASE DURATION; FEMALE; GROUPS BY AGE; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; OUTCOME ASSESSMENT; PATIENT DECISION MAKING; PREDICTION; PRIORITY JOURNAL; RECURRENT DISEASE; SEX DIFFERENCE; TREATMENT FAILURE;

AGED; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CATHETER ABLATION; COMBINED MODALITY THERAPY; DRUG RESISTANCE; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATIONS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84860453506     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eur370     Document Type: Article

References (25)

1. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: Full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 2006;8:651-745.
2. Calkins H, Brugada J, Packer DL, Capppato R, Chen S, Crijns H et al. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for personnel, policy, procedures and follow-up. Europace 2007;9:335-79.
3. Wann LS, Curtis AB, January CT, Ellenbogen KA, Lowe JE, Estes NAM et al. ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation updating the 2006 guideline). Heart Rhythm 2011;8:157-76.
4. Camm AJ, Kirchhof P, Lip GYJ, Schotten U, Savelieva I, Ernst S et al. Guidelines for the management of atrial fibrillation. Eur Heart J 2010;31:2369-429.
5. Verma A, Macle L, Cos J, Skanes AC. Canadian cardiovascular society atrial fibrillation guidelines 2010: Catheter ablation for atrial fibrillation/atrial flutter. Can J Cardiol 2011;27:60-6.
6. The Atrial Fibrillation Follow-up Investigation of Rhythm Management Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-33.
7. Piccini JP, Lopes RD, Kong MH, Hasselblad V, Jackson KJ, Al-Khatib SM. Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation: A meta-analysis of randomized controlled trials. Circ Arrhythm Electrophysiol 2009;2:626-33.
8. Wazni OM, Marrouche NF, Martin DO, Verma A, Bhargava M, Saliba W et al. Radiofrequency ablation vs. Antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation : A randomized trial. JAMA 2005;293:2634-40.
9. Shah AN, Mittal S, Sichrovsky TC, Cotiga D, Arshad A, Maleki K et al. Long-term outcome following successful pulmonary vein isolation: Pattern and prediction of very late recurrence. J Cardiovasc Electrophysiol 2008;19:661-7.
10. Gerstenfeld EP, Sauer W, Callans DJ, Dixit S, Lin D, Russo AM et al. Predictors of success after selective pulmonary vein isolation of arrhythmogenic pulmonary veins for treatment of atrial fibrillation. Heart Rhythm 2006;3:165-70. (Pubitemid 43149989)
11. Tzou WS, Marchlinski FE, Zado ES, Lin D, Dixit S, Callans DJ et al. Long-term outcome after successful catheter ablation of atrial fibrillation. Circ Arrhythm Electrophysiol 2010;3:237-42.
12. Wokhlu A, Hodge DO, Monahan KH, Asirvatham SJ, Friedman PA, Munger TM et al. Long-term outcome of atrial fibrillation ablation: Impact and predictors of very late recurrence. J Cardiovasc Electrophysiol 2010;21:1071-6.
13. Patel D, Mohanty P, Di Biase L, Sanchez JE, Shaheen MH, Burkhardt JD et al. Outcomes and complications of catheter ablation for atrial fibrillation in females. Heart Rhythm 2010;7:167-72.
14. Bhargava M, Di Biase L, Mohanty P, Prasad S, Martin DO, Andrew MW et al. Impact of type of atrial fibrillation and repeat catheter ablation on long-term freedom of atrial fibrillation: Results from a multicenter study. Heart Rhythm 2009;6:1403-12.
15. Forleo GB, Tondo C, De Luca L, Dello Russo A, Casella M, De Sanctis V et al. Gender-related differences in catheter ablation of atrial fibrillation. Europace 2007;9:613-20. (Pubitemid 47263791)
16. Winkle RA, Mead RH, Engel G, Patrawala RA. Long term results of atrial fibrillation ablation: The importance of all initial ablation failures undergoing a repeat ablation. Am Heart J 2011;162:193-200.
17. Winkle RA, Mead RH, Engel G, Patrawala RA. Relation of early termination of persistent atrial fibrillation by cardioversion or drugs to ablation outcomes. Am J Cardiol 2011;108:374-9.
18. Winkle RA, Mead RH, Engel G, Patrawala RA. Atrial fibrillation ablation: Perpetual motion of open irrigated tip catheters at 50 watts is safe and improves outcomes. Pacing Clin Elecrophysiol 2011;34:531-9.
19. Winkle RA, Mead RH, Engel G, Patrawala RA. Safety of lower activated clotting times during atrial fibrillation ablation using open irrigated tip catheters and a single transseptal puncture. Am J Cardiol 2011;107:704-8.
20. Winkle RA, Mead RH, Engel G, Patrawala RA. The use of a radiofrequency needle improves the safety and efficacy of transseptal puncture for atrial fibrillation ablation. Heart Rhythm 2011;8:411-15.
21. Gillis AM, Skanes AC. Comparing the 2010 North American and European Atrial Fibrillation Guidelines. Can J Cardiol 2011;27:7-13.
22. Cappato R, Calkins H, Chen SA, Chen S, Davies W, Iesaka Y et al. Worldwide survey on the methods, efficacy and safety of catheter ablation for human atrial fibrillation. Circulation 2005;111:1100-5. (Pubitemid 40365469)
23. Tanner H, Makowki K, Roten L, Seiler J, Schwick N, Müller C et al. Catheter ablation of atrial fibrillation as first-line therapy - a single-centre experience. Europace 2011;13:646-53.
24. Weerasooriya R, Khairy P, Litalien J, Macle L, Hocini M, Sacher F et al. Catheter ablation for atrial fibrillation. Are results maintained at 5 years of follow-up? J Am Coll Cardiol 2011;57:160-6.
25. Cheema A, Vasamraddy CR, Dalal D, Dalal D, Marine JE, Dong J et al. Long-term single procedure efficacy of atrial fibrillation ablation. J Interv Card Electrophysiol 2006;15:145-55. (Pubitemid 44510957)